Savvy Updates 6/20/22: Study to Regenerate Beta Cells, Senseonics Eversense E3 180-day CGM Gets CE Mark, Piezoelectric Button to Control T1D, Insulin & Weight Gain, Lager Beer Improves Gut Health, Best Time to Exercise Differs by Sex, Recession Impact on Medical Device Growth
New potential diabetes treatment regenerates insulin-producing cells was written by Michael Irving for NewAtlas.com, 13 June 2022. An emerging way to treat diabetes is to repair or replace the cells in the body that naturally produce insulin. Swedish researchers have...
Savvy Hot News, 6/17/22: FTC votes unanimously to increase scrutiny over PBMs ~ FOCUS on INSULIN!
FTC votes unanimously to increase scrutiny over pharmacy agent fees was reported by Dulan Lokuwithana for SeekingAlpha.com, 16 June 2022. The Federal Trade Commission (FTC) voted unanimously to adopt a policy statement stating its intention to more closely examine the...
Savvy Updates 6/13/22: Dexcom vs. Abbott, CREATE Trial: DIY Insulin Delivery System Safe, Effective, Gluroo App
Dexcom and Abbott’s fight over glucose monitoring patents intensifies in Europe was posted by Amy Sandys for Juve-Patent.com, 20 May 2022. Dexcom and Abbott are currently going head-to-head over twelve separate patents covering their respective glucose monitoring...
Savvy Updates 6/8/22: More on Dexcom, CGM Accuracy Study, CGM Alarm Fatigue, Prior Authorizations Reform (NOT)
More on Dexcom: Dexcom CEO Sayer on G7 FDA submission, developing a 15-day sensor, M&A plans was published by Ricky Zipp for MedTechDive.com, 7 June 2022. The executive spoke about the company’s discussions with the FDA on the G7 CGM system,...
Savvy Updates, 6/6/22: Abbott Libre 3 & Lingo, Diabeloop $$, iLet Bionic Pancreas Trial, Apple Watch BG Monitoring, Medtronic Struggles, Diabetes & Long Covid, Dexcom Denies Rumors, Pharmacy Benefit Managers Cost Consumers
ABBOTT NEWS US FDA approves Abbott’s FreeStyle Libre 3 system for diabetic patients was reported by MedicalDevice-Network.com, 1 June 2022. The US Food and Drug Administration (FDA) has granted clearance to Abbott’s next-generation FreeStyle...
Savvy Updates 5/30/22: Dexcom-Insulet Purchase Discussion, Medtronic’s Continuing Supply Chain Woes, Levicure Ltd Aims for Oral Treatment for T1D
How a Dexcom-Insulet combination would shake up the diabetes treatment industry was published by Ricky Zipp for MedTechDive.com, 25 May 2022. After last year’s barrage of deal-making in the medical device industry, there have been few acquisitions in...
Open Letter to the US FDA from The Savvy Diabetic re FDA, Interoperability Mandate and End-User On-Device, Continuous Access to OUR OWN CGM DATA
OPEN LETTER to: • Robert M. Califf, M.D., Commissioner of Food & Drugs, USFDA • Jeffrey E. Shuren, M.D., J.D. Director, Ctr for Devices & Radiological Health, US FDA • Kellie Kelm, Ph.D, Director, Office of Health Technology 7, US FDA • Yiduo Wu, Ph.D., Branch...
Savvy NEWS FLASH, 5/24/22: Dexcom Is in Talks to Acquire Device Firm Insulet
WOW, BIG NEWS!!! Dexcom Is in Talks to Acquire Device Firm Insulet was reported by Ed Hammond and Michelle F. Davis for Yahoo.com/Finance, 23 May 2022. Dexcom Inc. is in talks to acquire medical-device company Insulet Corp. in a deal that would create a giant in...
Savvy Updates 5/23/22: Evotec/Sernova Beta Cell Replacement Therapy for Cure to Diabetes, How Kidneys Actually Work, Neuropathy & Diabetes Fatigue
Evotec, Sernova Striving for Functional Diabetes Cure was published by Alex Keown for BioSpace.com, 17 May 2022. Two life sciences powerhouses are coming together to develop an off-the-shelf beta cell replacement therapy for insulin-dependent diabetes patients,...
More Diabetes Blogs